DarioHealth Corp. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $15.36 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $13.03, a 729.94% increase year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $1.57, a 66.67% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $4.71, a 36.44% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $7.41, a 53.16% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $28.13, a 798.72% increase from fiscal 2024.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $3.13, a 46.59% decline from fiscal 2023.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $5.86, a 61.06% decline from fiscal 2022.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $15.05, a 2.21% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.36 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $13.03 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $28.13 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $27.19 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $1.50 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | $1.57 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $3.13 10-K · filed 2025-03-10 | |||
| 2024-09-30 | $3.63 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $4.02 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $4.71 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $5.86 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $7.05 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $8.31 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $7.41 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $15.05 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $14.95 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $13.91 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $15.82 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $15.39 10-K · filed 2022-03-22 | |||
| 2021-09-30 | $16.93 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $14.66 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $23.51 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $13.45 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $13.11 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $12.95 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | $13.22 10-Q · filed 2020-05-12 | |||
| 2019-12-31 | $20.98 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $1.05 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | $1.58 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $1.91 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $6.08 10-K · filed 2019-03-25 | |||
| 2017-12-31 | $4.62 10-K · filed 2018-03-19 | |||
| 2016-12-31 | $18.29 10-K · filed 2017-03-22 | |||
| 2015-12-31 | $2.05 10-K · filed 2016-02-08 | |||
| 2015-09-30 | $4.14 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | $4.14 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $3.07 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $13.54 10-K · filed 2015-03-24 | |||
| 2013-12-31 | $1.53 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |